Myriad Genetics Inc (MYGN)
17.60
-0.24
(-1.32%)
USD |
NASDAQ |
Nov 05, 16:00
Myriad Genetics 1 Year Total Returns (Daily): 4.76% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | 4.76% |
November 01, 2024 | 14.29% |
October 31, 2024 | 40.95% |
October 30, 2024 | 57.25% |
October 29, 2024 | 60.10% |
October 28, 2024 | 57.87% |
October 25, 2024 | 46.77% |
October 24, 2024 | 39.81% |
October 23, 2024 | 45.98% |
October 22, 2024 | 50.10% |
October 21, 2024 | 49.57% |
October 18, 2024 | 55.31% |
October 17, 2024 | 56.47% |
October 16, 2024 | 60.32% |
October 15, 2024 | 64.92% |
October 14, 2024 | 72.63% |
October 11, 2024 | 57.69% |
October 10, 2024 | 50.59% |
October 09, 2024 | 62.36% |
October 08, 2024 | 70.23% |
October 07, 2024 | 71.41% |
October 04, 2024 | 69.03% |
October 03, 2024 | 71.07% |
October 02, 2024 | 73.82% |
October 01, 2024 | 68.52% |
Date | Value |
---|---|
September 30, 2024 | 70.76% |
September 27, 2024 | 62.63% |
September 26, 2024 | 64.04% |
September 25, 2024 | 56.23% |
September 24, 2024 | 59.84% |
September 23, 2024 | 62.13% |
September 20, 2024 | 62.59% |
September 19, 2024 | 62.96% |
September 18, 2024 | 67.18% |
September 17, 2024 | 72.19% |
September 16, 2024 | 67.97% |
September 13, 2024 | 72.44% |
September 12, 2024 | 61.70% |
September 11, 2024 | 61.13% |
September 10, 2024 | 69.11% |
September 09, 2024 | 69.73% |
September 06, 2024 | 57.17% |
September 05, 2024 | 60.63% |
September 04, 2024 | 40.73% |
September 03, 2024 | 52.39% |
August 30, 2024 | 55.49% |
August 29, 2024 | 58.48% |
August 28, 2024 | 59.02% |
August 27, 2024 | 55.37% |
August 26, 2024 | 56.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-73.94%
Minimum
Aug 04 2020
202.0%
Maximum
Mar 17 2021
8.20%
Average
-11.20%
Median
1 Year Total Returns (Daily) Benchmarks
Boston Scientific Corp | 61.28% |
Abbott Laboratories | 25.23% |
Personalis Inc | 346.4% |
Perspective Therapeutics Inc | 345.9% |
Electromed Inc | 119.8% |